More articles Cell Therapeutics, Inc

More articles Stem Cell Companies

More articles Stem Cell Stocks

More articles BioMimetic Therapeutics (BMTI)

More articles Pluristem Therapeutics-PTSI

More articles Osiris Therapeutics-OSIR

More articles Cytori Therapeutics, Inc.

More articles ThermoGenesis (KOOL)

More articles Nutra Pharma (OTCBB:NPHC)

More articles Human Embryonic Stem Cell Market

More articles RTI Biologics (RTIX)

More articles Aastrom Biosciences -ASTM



XOMA 052 Designated Orphan Drug by FDA ...
Published:Wed, 04 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, ......
XOMA to Announce 2010 Second Quarter Fi...
Published:Mon, 02 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of antibody therapeutics, announced that the company will host a webcast conference call on Monday, Augus......
XOMA 052 Orphan Drug Designation for Be...
Published:Thu, 29 Jul 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medic......
Biotech Stocks: Depomed, Dendreon lead ...
Published:Wed, 04 Aug 2010 07:55:59 -0700
Depomed lead gains among drug stocks a day after it said Pfizer will not file a patent infringement lawsuit to prevent the launch of a painkiller.......
Trader Favorite Dendreon Spikes On Prov...
Published:Wed, 04 Aug 2010 08:00:00 -0700
After soaring higher on the FDA approval of its Provenge prostate cancer vaccine in April, volatile Dendreon quickly retreated to well below its pre-approval pricing, but sales fi......
© 2010 | Privacy Policy | Powered By Noomle.com | SiteMap